Personal information

Activities

Employment (1)

Maria Sklodowska-Curie National Research Institute of Oncology: Warsaw, PL

1994-10 to present | Head, associate professor (Flow Cytometry Laboratory, Department of Cancer Pathomorphology )
Employment
Source: Self-asserted source
Grzegorz Rymkiewicz

Education and qualifications (1)

Akademia Medyczna: Poznań, Warszawa, PL

1987 to 1993
Education
Source: Self-asserted source
Grzegorz Rymkiewicz

Works (50 of 80)

Items per page:
Page 1 of 2

microRNA Profile of High-Grade B-Cell Lymphoma with 11q Aberration

International Journal of Molecular Sciences
2024-12-31 | Journal article
Contributors: Michalina Zajdel; Łukasz Michał Szafron; Agnieszka Paziewska; Grzegorz Rymkiewicz; Michalina Dąbrowska; Zbigniew Bystydzieński; Mariusz Kulińczak; Beata Grygalewicz; Maria Sromek; Katarzyna Błachnio et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology

Modern Pathology
2024-01 | Journal article
Part of ISSN: 0893-3952
Contributors: Richard Colling; Iciar Indave; Javier del Aguila; Ramon Cierco Jimenez; Fiona Campbell; Magdalena Chechlińska; Magdalena Kowalewska; Stefan Holdenrieder; Inga Trulson; Karolina Worf et al.
Source: Self-asserted source
Grzegorz Rymkiewicz

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the dura mimicking meningioma: a case report and literature review

Folia Neuropathol 2024; 62 (1): 1-6
2024-01 | Journal article
Contributors: Grzegorz Rymkiewicz
Source: Self-asserted source
Grzegorz Rymkiewicz

Cytogenomic features of Richter transformation.

Molecular cytogenetics
2023-11-08 | Journal article
Contributors: Woroniecka R; Rymkiewicz G; Bystydzienski Z; Pienkowska-Grela B; Rygier J; Malawska N; Wojtkowska K; Goral N; Blachnio K; Chmielewski M et al.
Source: Self-asserted source
Grzegorz Rymkiewicz

Data from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Data from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Supplementary Materials from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Supplementary Materials from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Supplementary Table from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Supplementary Table from Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

2023-03-31 | Preprint
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine ( <scp>R‐MIV</scp> ) in patients with primary <scp>CNS</scp> lymphoma including recent <scp>COVID</scp> ‐19 pandemic experience

British Journal of Haematology
2023-02-10 | Journal article
Part of ISSN: 0007-1048
Part of ISSN: 1365-2141
Contributors: Beata Ostrowska; Katarzyna Domanska Czyz; Joanna Romejko-Jarosińska; Michal Osowiecki; Lukasz Targonski; Lidia Poplawska; Robert Konecki; Martyna Kotarska; Marcin Szymanski; Anna Borawska et al.
Source: Self-asserted source
Grzegorz Rymkiewicz

Predictive role of NKCD56bright cells in monitoring the progression of chronic lymphocytic leukemia during treatment

Folia Histochemica et Cytobiologica
2022-09-01 | Journal article
Part of ISSN: 1897-5631
Part of ISSN: 0239-8508
Contributors: Grzegorz Rymkiewicz
Source: Self-asserted source
Grzegorz Rymkiewicz

Development and Characterization of 3D Hybrid Spheroids for the Investigation of the Crosstalk Between B-Cell Non-Hodgkin Lymphomas and Mesenchymal Stromal Cells

OncoTargets and Therapy
2022-06 | Journal article
Contributors: Kamila Duś-Szachniewicz; Katarzyna Gdesz-Birula; Grzegorz Rymkiewicz
Source: check_circle
Crossref

High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.

Scientific reports
2022-06-22 | Journal article
Source: Self-asserted source
Grzegorz Rymkiewicz

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma

Brithish Journal of Haematology
2022-04-01 | Journal article
Source: Self-asserted source
Grzegorz Rymkiewicz

Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma - Real World Report of Polish Lymphoma Research Group

Chemotherapy
2022-03-04 | Journal article
Part of ISSN: 0009-3157
Part of ISSN: 1421-9794
Source: Self-asserted source
Grzegorz Rymkiewicz

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature

PLOS ONE
2022-02-15 | Journal article
Part of ISSN: 1932-6203
Source: Self-asserted source
Grzegorz Rymkiewicz

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Cancer Research
2021-12-01 | Journal article
Contributors: Maciej Szydłowski; Filip Garbicz; Ewa Jabłońska; Patryk Górniak; Dorota Komar; Beata Pyrzyńska; Kamil Bojarczuk; Monika Prochorec-Sobieszek; Anna Szumera-Ciećkiewicz; Grzegorz Rymkiewicz et al.
Source: check_circle
Crossref

A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors

Biomolecules
2021-09-21 | Journal article
Contributors: Maria Sromek; Grzegorz Rymkiewicz; Agnieszka Paziewska; Lukasz Michal Szafron; Maria Kulecka; Michalina Zajdel; Mariusz Kulinczak; Michalina Dabrowska; Aneta Balabas; Zbigniew Bystydzienski et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(−) Subtype

Cancers
2021-04-15 | Journal article
Contributors: Beata Ostrowska; Grzegorz Rymkiewicz; Magdalena Chechlinska; Katarzyna Blachnio; Katarzyna Domanska-Czyz; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Anita Borysiuk; Sebastian Rybski; Wojciech Michalski et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis

Cancers
2021-02-05 | Journal article
Contributors: Kamila Duś-Szachniewicz; Grzegorz Rymkiewicz; Anil Kumar Agrawal; Paweł Kołodziej; Jacek R. Wiśniewski
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation

Scientific Reports
2020-09-03 | Journal article
Contributors: Anna Szumera-Ciećkiewicz; Urszula Wojciechowska; Joanna Didkowska; Jan Poleszczuk; Grzegorz Rymkiewicz; Ewa Paszkiewicz-Kozik; Kamil Sokół; Monika Prochorec-Sobieszek; Jan Walewski
Source: check_circle
Crossref

Poster ALK-LBCL

Unpublished
2019 | Journal article
Source: Self-asserted source
Grzegorz Rymkiewicz

Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers

Scientific Reports
2019-12 | Journal article
Part of ISSN: 2045-2322
Source: Self-asserted source
Grzegorz Rymkiewicz

First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4

British Journal of Haematology
2019-12-02 | Journal article
Part of ISSN: 0007-1048
Part of ISSN: 1365-2141
Source: Self-asserted source
Grzegorz Rymkiewicz

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx), Plus Rituximab (R) in Case of B-Cell Lymphoma

Blood
2019-11-13 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

The whole-genome landscape of Burkitt lymphoma subtypes

Blood
2019-11-07 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas

Cancers
2019-10-25 | Journal article
Part of ISSN: 2072-6694
Source: Self-asserted source
Grzegorz Rymkiewicz

MOLECULAR ANALYSES AND AN INNOVATIVE DIAGNOSTIC ALGORITHM IN MYC -NEGATIVE BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION: A SINGLE INSTITUTION EXPERIENCE

Hematological Oncology
2019-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R-CHOP AND WERE NOT CANDIDATES FOR HIGH-DOSE THERAPY AND ASCT - PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG-8)

Hematological Oncology
2019-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

Validation of theMCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

British Journal of Haematology
2019-02 | Journal article
Part of ISSN: 0007-1048
Part of ISSN: 1365-2141
Source: Self-asserted source
Grzegorz Rymkiewicz

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

Blood
2019-02-28 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Blood
2019-02-28 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation’s 2017 classification

Polish Journal of Pathology
2018 | Journal article
Part of ISSN: 1233-9687
Source: Self-asserted source
Grzegorz Rymkiewicz

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Blood
2018-11-29 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration

Modern Pathology
2018-05 | Journal article
Part of ISSN: 0893-3952
Part of ISSN: 1530-0285
Source: Self-asserted source
Grzegorz Rymkiewicz

The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma

Oncogene
2018-04 | Journal article
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Source: Self-asserted source
Grzegorz Rymkiewicz

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

Blood
2018-01-25 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS

American Journal of Clinical Pathology
2018-01-01 | Journal article
Part of ISSN: 0002-9173
Part of ISSN: 1943-7722
Source: Self-asserted source
Grzegorz Rymkiewicz

Two neoplasms rich in small lymphocytes, B1B2 thymoma and small lymphocytic lymphoma, intermingled in one tumor mass. A case report

Polish Journal of Pathology
2017 | Journal article
Part of ISSN: 1233-9687
Source: Self-asserted source
Grzegorz Rymkiewicz

Abstract 2161: Pharmacological downregulation of BFL-1 by the BET bromodomain inhibitor CPI203 overcomes ABT-199 resistance inMYC+/BCL2+double hit lymphoma

Experimental and Molecular Therapeutics
2017-07-01 | Conference paper
Source: Self-asserted source
Grzegorz Rymkiewicz

MCL-R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK  ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R-CHOP / R-HAD) AND a RITUXIMAB-LENALIDOMIDE MAINTENANCE

Hematological Oncology
2017-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

P53 BUT NOT SOX11 IHC HAS PROGNOSTIC VALUE INDEPENDENT OF MIPI AND KI-67 IN PROSPECTIVE TRIALS OF THE EUROPEAN-MCL NETWORK

Hematological Oncology
2017-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

R- DAEPOCH as a first line treatment for high grade B cell lymphoma and diffuse large B cell lymphoma with unfavorable features

Hematological Oncology
2017-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

R-CHOP is not effective regimen in CD5(+)DLBCL diagnosed by flow-cytometry/immunohistochemistry, karyotype and BCL2/BCL6 status and expression

Hematological Oncology
2017-06 | Journal article
Part of ISSN: 0278-0232
Source: Self-asserted source
Grzegorz Rymkiewicz

Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation

Clinical and Experimental Medicine
2017-05 | Journal article
Part of ISSN: 1591-8890
Part of ISSN: 1591-9528
Source: Self-asserted source
Grzegorz Rymkiewicz

The outcome of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements or NOS compared to DLBCL patients from a single institution.

Journal of Clinical Oncology
2017-05-20 | Journal article
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Grzegorz Rymkiewicz

IgG4‑related disease as an unusual cause of biliary stenosis and lymphadenopathy

Polish Archives of Internal Medicine
2017-03-21 | Journal article
Part of ISSN: 1897-9483
Source: Self-asserted source
Grzegorz Rymkiewicz

Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)

Molecular Cytogenetics
2016-12 | Journal article
Part of ISSN: 1755-8166
Source: Self-asserted source
Grzegorz Rymkiewicz

DA-EPOCH-R Is an Effective Regimenin High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2/MYC/BCL6 Status and Expression

Blood
2016-12-02 | Journal article
Part of ISSN: 0006-4971
Part of ISSN: 1528-0020
Source: Self-asserted source
Grzegorz Rymkiewicz
Items per page:
Page 1 of 2